148 related articles for article (PubMed ID: 4608944)
21. A review of drug "clearance times" in racehorses.
Moss MS
Equine Vet J; 1977 Apr; 9(2):53-6. PubMed ID: 324761
[TBL] [Abstract][Full Text] [Related]
22. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics in the elderly.
Triggs EJ; Nation RL; Long A; Ashley JJ
Eur J Clin Pharmacol; 1975; 8(1):55-62. PubMed ID: 1233203
[TBL] [Abstract][Full Text] [Related]
24. Effects of liver disease on drug disposition in man.
Wilkinson GR; Schenker S
Biochem Pharmacol; 1976 Dec; 25(24):2675-81. PubMed ID: 795432
[No Abstract] [Full Text] [Related]
25. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
Levi AJ; Sherlock S; Walker D
Lancet; 1968 Jun; 1(7555):1275-9. PubMed ID: 4172137
[No Abstract] [Full Text] [Related]
26. [Effects of liver disease on drug pharmacokinetics].
Su CY
Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
[No Abstract] [Full Text] [Related]
27. [Dangerous drugs in hepatic insufficiency].
Isal JP; Caulin C
Med Chir Dig; 1979; 8(5):447-9. PubMed ID: 534025
[No Abstract] [Full Text] [Related]
28. [Clinical significance of disorders of drug kinetics in liver diseases].
Bolanowski M; Orzechowska-Juzwenko K
Pol Arch Med Wewn; 1986 Apr; 75(4):288-96. PubMed ID: 3540881
[No Abstract] [Full Text] [Related]
29. Effect of eucalyptol (1,8-cineole) on the metabolism of other drugs in rats and in man.
Jori A; Bianchetti A; Prestini PE; Gerattini S
Eur J Pharmacol; 1970 Mar; 9(3):362-6. PubMed ID: 5440307
[No Abstract] [Full Text] [Related]
30. Application of stable labelled drugs in clinical pharmacokinetic investigations.
Eichelbaum M; von Unruh GE; Somogyi A
Clin Pharmacokinet; 1982; 7(6):490-507. PubMed ID: 6819104
[No Abstract] [Full Text] [Related]
31. Hepatic circulation and drug disposition in cirrhosis.
Shand DG
Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
[No Abstract] [Full Text] [Related]
32. Terminal half-lives of drugs studied in patients with hepatic diseases.
Closson RG
Am J Hosp Pharm; 1977 May; 34(5):520-4. PubMed ID: 326043
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiological factors influencing drug kinetics.
Breckenridge A
Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():225-32. PubMed ID: 5316404
[No Abstract] [Full Text] [Related]
34. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
Larrey D; Branch RA
Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
[No Abstract] [Full Text] [Related]
35. Activity and inducibility of hepatic microsomal enzymes in liver diseases.
Singh D; Vijayvargiya R; Kakrani AL
Indian J Med Res; 1977 Nov; 66(5):832-9. PubMed ID: 608753
[No Abstract] [Full Text] [Related]
36. [Drug metabolism in patients with liver disease (author's transl)].
Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
[TBL] [Abstract][Full Text] [Related]
37. Effect of acute and chronic exercise on hepatic drug metabolism.
Døssing M
Clin Pharmacokinet; 1985; 10(5):426-31. PubMed ID: 3899456
[TBL] [Abstract][Full Text] [Related]
38. Impaired elimination of meperidine in patients with liver disease.
McHorse TS; Klotz U; Wilkinson G; Schenker S
Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737
[No Abstract] [Full Text] [Related]
39. [Dose adaptation of drugs for liver patients using a simple risk classification].
Zysset T; Bircher J
Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
[No Abstract] [Full Text] [Related]
40. The influence of liver diseases on drug disposition.
Roberts RK; Branch RA; Desmond PV; Schenker S
Clin Gastroenterol; 1979 Jan; 8(1):105-21. PubMed ID: 369741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
